OMS201 is being developed for use during urological surgery. OMS201 is a proprietary combination of an anti-inflammatory agent and a smooth muscle relaxant. Both active agents are contained in generic, FDA-approved drugs with well-known profiles of safety and pharmacologic activities, and each is contained in drugs that have been marketed in the U.S. for more than 15 years.

Added to standard irrigation solutions in urological surgery, OMS201 is delivered directly to the surgical site during uroendoscopic procedures, such as bladder endoscopy, minimally invasive prostate surgery and ureteroscopy, to inhibit surgically induced inflammation, pain and smooth muscle spasm.

We are currently conducting a Phase 1 clinical trial to evaluate the safety and systemic absorption of OMS201 delivered to patients undergoing ureteroscopy for removal of ureteral or renal stones. We expect to complete this clinical trial in the second half of 2008.